Role of cardiac magnetic resonance imaging in troponinemia syndromes

This article was originally published here

World J Cardiol. 2022 Apr 26;14(4):190-205. doi: 10.4330/wjc.v14.i4.190.

ABSTRACT

Cardiac magnetic resonance imaging (MRI) is an evolving technology, proving to be a highly accurate tool for quantitative assessment. Most recently, it has been increasingly used in the diagnostic and prognostic evaluation of conditions involving an elevation in troponin or troponinemia. Although an elevation in troponin is a nonspecific marker of myocardial tissue damage, it is a frequently ordered investigation leaving many patients without a specific diagnosis. Fortunately, the advent of newer cardiac MRI protocols can provide additional information. In this review, we discuss several conditions associated with an elevation in troponin such as myocardial infarction, myocarditis, Takotsubo cardiomyopathy, coronavirus disease 2019 related cardiac dysfunction and athlete’s heart syndrome.

PMID:35582465 | PMC:PMC9048277 | DOI:10.4330/wjc.v14.i4.190